Hartford Investment Management CO Novo Nordisk A S Transaction History

Hartford Investment Management CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 16, 2023	BUY	$90.94 - $199.54 $138,956 - $304,897	1,528 Added 63.77%	3,924 $356,000
Q2 2023 Jul 19, 2023	SELL	$155.98 - $172.65 $253,155 - $280,210	-1,623 Reduced 40.38%	2,396 $387,000
Q4 2022 Jan 20, 2023	SELL	$102.55 - $135.33 $5,332 - $7,037	-52 Reduced 1.28%	4,019 $544,000
Q3 2022 Nov 02, 2022	SELL	$95.28 - $116.93 $70,983 - $87,112	-745 Reduced 15.47%	4,071 $406,000
Q2 2022 Jul 22, 2022	SELL	$103.24 - $121.81 $87,031 - $102,685	-843 Reduced 14.9%	4,816 $537,000
Q2 2020 Aug 04, 2020	BUY	$58.54 - $67.94 $331,277 - $384,472	5,659 New	5,659 $371,000

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $245B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

Stay updated on Hartford Investment Management CO with notifications on news.